Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2179)	4/1/2008 11:23:20 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CGEN Is up 9.5% on light volume of 12,599 which is about half its ADV It announced today the discovery and verification of CGEN-144, a variant of Troponin I biomarker,& the signing of a research & license agreement with Biosite. A patent for the biomarker has been granted by the FDA. The stock needs to close above its March27-March28 double top at the $2.35 level before it can get off the DT coming from its Jan H at $2.80 bigcharts.marketwatch.com The Aug 2000 H was $19.50 <g> bigcharts.marketwatch.com Bernard